Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran private equity and operational leader focused on growth-stage technology and healthcare investments, Katherine Stoner leverages prior operating roles and board experience to source and scale portfolio companies. Known for driving commercial strategy, talent development and buy-and-build execution, she works across capital formation, M&A and governance with an emphasis on revenue expansion and margin improvement in software-enabled services.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
Veteran operator-investor targeting growth-stage software-enabled healthcare and enterprise tech companies. Prioritizes revenue-centric value creation through go-to-market scaling, talent and leadership upgrades, and buy-and-build consolidation to expand margins and market share. Allocates capital into companies with validated product-market fit, recurring revenue and clear paths to unit-economics improvement, favoring active board governance and staged equity with performance-linked milestones. Time horizon is multi-year growth, risk-managed via operational intervention and disciplined follow-on reserve strategy.
| Trades 6004 | Longs Won 4316/6004 71% | Profit Factor 10.5 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $24.58M |
| Average Win $2.75M | Best Trade (Jul 13) $1.43B | Sharpe Ratio -11.85 |
| Average Loss -$670,521.96 | Worst Trade (Jul 13) -$63.87M | Z-Score 26.46 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 1w 4d | Expectancy $1.79M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 62,500 | 56,250 | 50,000 | 43,750 | 37,500 | 31,250 | 25,000 | 18,750 | 12,500 | 6,250 |